BriaCell Therapeutics Corp Financial Flexibility Index
BriaCell Therapeutics Corp financial flexibility index. BriaCell Therapeutics Corp (BCTXW) has a Financial Flexibility Index of -2.41x as of January 2026. Free cash flow of $-8.09 Million (operating CF $-8.09 Million minus capex $0.00) represents -2% of total liabilities ($3.35 Million). See how much free cash does BriaCell Therapeutics Corp generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BriaCell Therapeutics Corp (2006–2025)
Financial flexibility index of BriaCell Therapeutics Corp from 2006 to 2025. Historical Financial Flexibility Index trend for BriaCell Therapeutics Corp across 20 annual periods. Check cash flow quality index of BriaCell Therapeutics Corp to evaluate the quality of earnings relative to operating cash generation.
BriaCell Therapeutics Corp Financial Flexibility Index by Year (2006–2025)
BriaCell Therapeutics Corp financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for BriaCell Therapeutics Corp. For the full cash flow conversion analysis, see BCTXW cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.53x | $-28.17 Million | $-28.17 Million | $4.32 Million | ▼ -136.0% |
| 2024 | -2.77x | $-23.67 Million | $-24.13 Million | $8.56 Million | ▼ -260.4% |
| 2023 | -0.77x | $-23.74 Million | $-23.74 Million | $30.94 Million | ▼ -98.2% |
| 2022 | -0.39x | $-12.48 Million | $-12.48 Million | $32.25 Million | ▲ +96.1% |
| 2021 | -9.90x | $-7.75 Million | $-7.75 Million | $782.24K | ▼ -3123.4% |
| 2020 | -0.31x | $-1.16 Million | $-1.16 Million | $3.77 Million | ▲ +91.6% |
| 2019 | -3.66x | $-3.87 Million | $-3.87 Million | $1.06 Million | ▼ -28.8% |
| 2018 | -2.84x | $-3.81 Million | $-3.81 Million | $1.34 Million | ▼ -63.9% |
| 2017 | -1.73x | $-1.54 Million | $-1.54 Million | $885.90K | ▲ +93.0% |
| 2016 | -24.68x | $-1.20 Million | $-1.20 Million | $48.59K | ▼ -209.7% |
| 2015 | -7.97x | $-933.52K | $-935.26K | $117.17K | ▼ -6563.5% |
| 2014 | -0.12x | $-219.72K | $-363.97K | $1.84 Million | ▼ -112.2% |
| 2013 | 0.98x | $73.24K | $-368.52K | $74.46K | ▼ -86.9% |
| 2012 | 7.49x | $2.13 Million | $-381.49K | $283.94K | ▲ +137.2% |
| 2011 | 3.16x | $1.77 Million | $-690.76K | $559.43K | ▼ -46.5% |
| 2010 | 5.91x | $172.30K | $-309.37K | $29.15K | ▲ +369.8% |
| 2009 | -2.19x | $-140.59K | $-140.59K | $64.19K | ▲ +60.8% |
| 2008 | -5.59x | $-87.41K | $-87.41K | $15.64K | ▲ +39.0% |
| 2007 | -9.16x | $-87.76K | $-87.76K | $9.58K | ▼ -13543.1% |
| 2006 | 0.07x | $1.13K | $1.13K | $16.54K | — |